학술논문

Treatment of neonatal fungal infective endocarditis with recombinant tissue plasminogen: activator in a low birth weight infant case report and review of the literature.
Document Type
Article
Source
Mycoses. Oct2015, Vol. 58 Issue 10, p578-581. 4p.
Subject
*INFECTIVE endocarditis
*LOW birth weight
*PLASMINOGEN activators
*SEPSIS
*ANTIFUNGAL agents
*THERAPEUTICS
Language
ISSN
0933-7407
Abstract
With advances in medical sciences, an increase in survival rates of low birth weight; increased incidence in use of catheter and antibiotics, and total parenteral nutrition are reported, therefore, the rate of fungal infections in late and very late onset neonatal sepsis have increased. Although fungal endocarditis rarely occur in newborns, it has a high morbidity and mortality. Antifungal therapy is often insufficient in cases who develop fungal endocarditis and surgical treatment is not preferred due to its difficulty and high mortality. Herein, fungal endocarditis in a preterm newborn treated with single-dose recombinant tissue plasminogen activator in addition to antifungal therapy is presented and relevant literature has been reviewed. The vegetation completely disappeared following treatment and no complication was observed. [ABSTRACT FROM AUTHOR]